Sanofi, GSK launch trial for COVID-19 vaccine

Sanofi, GSK launch trial for COVID-19 vaccine

Drugmakers Sanofi and GlaxoSmithKline say they have launched clinical trials of their protein-based vaccine against COVID-19.

Share:

Comments

Comentarios de Facebook